Insights

Referenced briefings.

Analysis of AI in healthcare and pharma, grounded in peer-reviewed trials, regulatory data, and primary sources. Every claim is cited.

Healthcare·6 min read·30 June 2026

The FDA has now cleared over 1,400 AI medical devices, and radiology owns three quarters of them

The regulator authorised more AI-enabled devices in 2025 than in any year on record. The numbers show where clinical AI is actually landing, and where it is not.

Read briefing

Pharma·7 min

The first drug designed by generative AI just posted real Phase II lung-function data

Insilico Medicine's rentosertib improved lung function in idiopathic pulmonary fibrosis in a randomised trial published in Nature Medicine, the clearest clinical proof point yet for AI-driven discovery.

12 June 2026

Healthcare·5 min

Ambient AI scribes are the rare health-AI tool with a clear return, and the data is starting to back it

A multi-site study across six US health systems tied ambient documentation tools to measurable drops in burnout and documentation time. This is where clinical AI is quietly winning.

20 May 2026

Healthcare·6 min

A 105,000-woman trial shows AI can raise cancer detection and halve reading workload

The MASAI randomised controlled trial is the strongest evidence yet that AI-supported mammography works at population scale. Final results landed in The Lancet.

15 April 2026